SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-000391
Filing Date
2018-01-24
Accepted
2018-01-24 16:04:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 a2234356z424b5.htm 424B5 327784
2 G699186.JPG g699186.jpg GRAPHIC 8985
3 G279691.JPG g279691.jpg GRAPHIC 16093
4 G391312.JPG g391312.jpg GRAPHIC 91585
5 G836066.JPG g836066.jpg GRAPHIC 18470
  Complete submission text file 0001047469-18-000391.txt   515531
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214409 | Film No.: 18545211
SIC: 2834 Pharmaceutical Preparations